Partner with Seclis Labs for an exclusive PCD Pharma Franchise with monopoly rights, WHO-GMP certified products, and dedicated support — everything you need to grow a successful pharma business across India.
A PCD Pharma Franchise — short for Propaganda Cum Distribution — is a business model in which a pharmaceutical company grants marketing and distribution rights to an individual or business in a defined territory. The franchise partner operates independently under the pharma company's brand, selling and promoting the company's products to doctors, hospitals, and pharmacies within their allocated area.
The PCD Pharma Franchise model has become one of the most popular business opportunities in India's healthcare sector. According to Invest India, the Indian pharmaceutical industry is valued at over USD 50 billion and growing at 10–12% CAGR — making it one of the most stable and profitable sectors for entrepreneurs to enter.
Unlike a regular distribution business, a PCD Pharma Franchise gives you monopoly rights in your territory — meaning no other partner from the same company can operate in your area. This exclusivity, combined with a ready-made product portfolio, promotional support, and established brand credibility, makes the PCD model significantly lower-risk than starting a pharma business from scratch.
At Seclis Labs, we have built our PCD Pharma Franchise programme around one core principle — partner success. We provide WHO-GMP certified medicines, comprehensive marketing support, and a dedicated relationship manager for every partner. Our franchise partners across 20+ states are a testament to the strength of this model when backed by the right company.
Choosing the right pharma company for your PCD franchise is the most important decision you'll make. Here's why our partners across India trust Seclis Labs.
Every product in our PCD Pharma Franchise portfolio is manufactured at WHO-GMP certified facilities and approved by DCGI — giving you and your doctors complete confidence.
We strictly follow a single-partner-per-area policy. Your PCD Pharma Franchise territory is protected — no other Seclis partner operates in your district or region.
Our PCD Pharma Franchise product list spans cardiology, orthopaedics, gynaecology, neurology, paediatrics, dermatology, gastroenterology, diabetology, and more — giving you more doctors to approach.
Every PCD Pharma Franchise partner gets a dedicated relationship manager — reachable round the clock for orders, product queries, and business guidance from day one.
Starting your PCD Pharma Franchise with Seclis is a straightforward process. We guide you through every step — from initial enquiry to your first order being dispatched.
All Seclis products are regulated and approved under the Drugs & Cosmetics Act, 1940 by the Central Drugs Standard Control Organisation (CDSCO), the national regulatory authority under the Ministry of Health & Family Welfare, Government of India.
Our manufacturing facilities comply with WHO Good Manufacturing Practices (GMP) guidelines, ensuring every product meets international quality standards.
The PCD Pharma Franchise model is one of the most viable small business opportunities in India's healthcare sector — here's why.
A PCD Pharma Franchise can be started with as little as ₹15,000, making it accessible to a wide range of entrepreneurs — from fresh graduates to experienced medical representatives.
Healthcare is a non-discretionary need. Demand for medicines remains constant regardless of economic conditions — making PCD Pharma Franchise one of the safest business models.
A PCD Pharma Franchise gives you complete independence. You set your own working hours, build your own doctor network, and grow at a pace that works for you.
As a PCD Pharma Franchise partner, you never need to worry about production, quality control, or regulatory compliance — Seclis handles all of that on your behalf.
India's pharmaceutical sector benefits from strong government support. Schemes like Pharma Vision 2020 and Ayushman Bharat continue to drive medicine demand and distribution expansion.
According to the India Brand Equity Foundation (IBEF), India's pharma market is expected to reach USD 130 billion by 2030 — creating enormous opportunity for PCD Pharma Franchise partners.
Our PCD Pharma Franchise product catalogue covers 300+ medicines across 12+ therapeutic segments. A wide portfolio means more doctors to approach, more prescriptions to capture, and more revenue streams for your business.
All products are manufactured in compliance with the CDSCO's Schedule M Good Manufacturing Practices and carry valid DCGI approvals. Every batch is quality-tested before dispatch.
View Full Product List →Join 500+ franchise partners across India. Exclusive monopoly rights, WHO-GMP certified products, and full support from day one.